Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KeraNetics is a commercial-stage biotechnology company focused on developing and manufacturing purified keratin-based products for regenerative medicine and healthcare. The company utilizes a proprietary platform to extract and purify human-derived keratin proteins, which are then formulated into various modalities such as hydrogels, powders, and supplements. Its lead commercial applications include wound care, radiation dermatitis management, and nutritional supplements for hair and skin health. KeraNetics aims to leverage the natural biological properties of keratin to enhance tissue repair and provide therapeutic solutions across multiple clinical areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KeraGLO.